ATE516013T1 - Gastroretentive zusammensetzung auf basis eines wasserlöslichen reaktionsprodukts eines vinylgruppen enthaltenden vorläufers - Google Patents

Gastroretentive zusammensetzung auf basis eines wasserlöslichen reaktionsprodukts eines vinylgruppen enthaltenden vorläufers

Info

Publication number
ATE516013T1
ATE516013T1 AT07863252T AT07863252T ATE516013T1 AT E516013 T1 ATE516013 T1 AT E516013T1 AT 07863252 T AT07863252 T AT 07863252T AT 07863252 T AT07863252 T AT 07863252T AT E516013 T1 ATE516013 T1 AT E516013T1
Authority
AT
Austria
Prior art keywords
reaction product
water
soluble reaction
gastroretentive composition
component
Prior art date
Application number
AT07863252T
Other languages
English (en)
Inventor
Shaukat Ali
Carlos Santos
Anisul Quadir
Original Assignee
Basf Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Corp filed Critical Basf Corp
Application granted granted Critical
Publication of ATE516013T1 publication Critical patent/ATE516013T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
AT07863252T 2007-07-06 2007-12-26 Gastroretentive zusammensetzung auf basis eines wasserlöslichen reaktionsprodukts eines vinylgruppen enthaltenden vorläufers ATE516013T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94821607P 2007-07-06 2007-07-06
PCT/US2007/026347 WO2009008873A1 (en) 2007-07-06 2007-12-26 A gastroretentive composition on the basis of a water-soluble reaction product from a vinyl group- containing precursor

Publications (1)

Publication Number Publication Date
ATE516013T1 true ATE516013T1 (de) 2011-07-15

Family

ID=39361424

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07863252T ATE516013T1 (de) 2007-07-06 2007-12-26 Gastroretentive zusammensetzung auf basis eines wasserlöslichen reaktionsprodukts eines vinylgruppen enthaltenden vorläufers

Country Status (5)

Country Link
US (1) US9622966B2 (de)
EP (1) EP2182917B1 (de)
AT (1) ATE516013T1 (de)
ES (1) ES2368356T3 (de)
WO (1) WO2009008873A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2133071A1 (de) * 2008-06-09 2009-12-16 Université de la Méditerranée Verfahren zur Herstellung gastroretentiver Darreichungsformen
PE20121316A1 (es) 2009-11-13 2012-10-05 Sanofi Aventis Deutschland Composicion farmaceutica que comprende un agonista de glp-1 y metionina
US20150359804A1 (en) * 2014-06-12 2015-12-17 Orbis Biosciences, Inc. Extended-release drug delivery compositions
US20220387311A1 (en) * 2019-11-08 2022-12-08 Lyndra Therapeutics, Inc. Gastric residence systems for administration of active agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2930762A (en) * 1957-08-08 1960-03-29 Universal Oil Prod Co Polyvinyl compounds as lubricants in pilling operations
US3634584A (en) * 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
DE10153934A1 (de) * 2001-11-06 2003-05-22 Basf Ag Verfahren zur Kristallisation von Profenen
AU2003299838A1 (en) * 2002-12-19 2004-07-14 Polymorfix, Inc. Ingestible formulations for transient, noninvasive reduction of gastric volume
US20040208931A1 (en) * 2002-12-30 2004-10-21 Friend David R Fast dissolving films for oral administration of drugs
US20050019400A1 (en) * 2003-01-27 2005-01-27 Deveney Thomas William Controlled-release drug delivery system
JP2006076971A (ja) * 2004-09-13 2006-03-23 Basf Ag 口腔内崩壊錠

Also Published As

Publication number Publication date
US9622966B2 (en) 2017-04-18
ES2368356T3 (es) 2011-11-16
WO2009008873A1 (en) 2009-01-15
EP2182917B1 (de) 2011-07-13
EP2182917A1 (de) 2010-05-12
US20120269866A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
DK1917339T3 (da) Film med rengøringsmidler
ATE516013T1 (de) Gastroretentive zusammensetzung auf basis eines wasserlöslichen reaktionsprodukts eines vinylgruppen enthaltenden vorläufers
EP4248766A3 (de) Rauchfreies orales tabakprodukt und herstellung davon
GEP20125378B (en) Pharmaceutical compositions
UY30472A1 (es) Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones.
MX2010004292A (es) Producto de dispersion solida que contiene un compuesto a base de n-aril urea.
EA201071218A1 (ru) Улучшенные композиции для активных фармацевтических компонентов с плохой проницаемостью
DK2178513T3 (da) Sammensætninger i tabletform indeholdende atazanavir
MX2018001453A (es) Nuevas formulaciones para adhesivos sensibles a la presion.
DE602008005316D1 (de) Tablettierte atazanavirhaltige zusammensetzungen
PH12016500825A1 (en) Composition useful for promoting female fertility
UA96622C2 (ru) Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования
MX2022012239A (es) Compuestos de amida y usos de los mismos.
ZA201807446B (en) Improved drug formulations
WO2008069938A3 (en) Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide
WO2009002821A3 (en) Tableted compositions containing atazanavir
MX2010004291A (es) Producto de dispersion solida de farmacos basados en n-aril urea.
WO2012024605A3 (en) Devices and methods for intravaginal delivery of drugs and other substances
MX2016008527A (es) Preparaciones solidas que contienen tofogliflozina y proceso para producir las mismas.
PH12018502105A1 (en) Use of amino sugar as plasticizer
JP2013523834A5 (de)
ATE500820T1 (de) Tablettierte atazanavirhaltige zusammensetzungen
WO2012082487A3 (en) Oxazolinyl-containing polymers and grafted compounds prepared from the oxazolinyl-containing polymers
WO2011025377A3 (en) Active ingredient delivery system
WO2008021875A3 (en) Pharmaceutical tablets containing a plurality of active segments

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties